Company intelligence / Profile preview

Nictavi

Los Angeles, California, United States
Ownership
Private
Employees
~2
Development stage
Other
01

Overview

Nictavi is a private ophthalmic medical device company focused on corneal care and eyelid-closure therapies. Its lead and apparently sole commercial product is the patented Tarsus Eyelid Patch, an FDA-listed eyelid closure device designed to help protect the ocular surface, retain moisture, and support healing in patients with conditions such as lagophthalmos, exposure-related corneal damage, and corneal epithelial defects. The company positions the patch for use across ophthalmology, optometry, pediatric eye care, surgical recovery, and hospital/ICU settings. Nictavi appears to operate as a niche medtech manufacturer and wholesaler rather than a drug-development biotech company. The business was founded by Nathan Horner based on a personal corneal disease journey and has received recognition and grant support from pediatric medtech innovation programs.

Therapeutic areas
Ophthalmology
Modalities
DeviceNon-pharmacological therapy
Industry
Consumable Medical Devices
02

Partnerships

Consortium for Technology & Innovation in PediatricsUCLA Jules Stein Eye InstituteChildren's Hospital Los Angeles Vision CenterScaleHealthUSC Roski Eye InstituteHi-Tech Products

Beyond the preview

Go deeper on Nictavi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nictavi.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call